AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Mar 17, 2016
30071_dirs_2016-03-17_ac8d061a-89b7-4812-93bc-318a3725b64e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-03-16
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-16 | ResMed Common Stock | A | 4680 | — | Acquired | 80291 | Indirect |
| 2016-03-16 | ResMed Common Stock | F | 2333 | — | Disposed | 77958 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 31304 | Direct |
Footnotes
F1: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.
F2: Shares earned, based on performance, at 40% of the target award.
F3: Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29